Anika Therapeutics Inc (ANIK)

CapEx to Revenue

4.44%

Quarterly · Period ending:

ANIK logo

ANIK CapEx to Revenue

Latest reported4.44%
ANIK Quarterly CapEx/Revenue (0.00% → 4.44%)
High-resolution chart · PNG

ANIK capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
16.8547%
6.1673%
1.2839%
1.2341%
7.6773%
3.343%
10%
17.1429%
10.5263%
12.5%
5.8824%
12.5%
23.913%
17.8571%
0%
0%
0%
0%
0%
7.6923%
0%
10%
22.2222%
22.2222%
0%
0%
0%
9.0909%
0%
0%
8.3333%
14.2857%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.